Cala Health has launched the kIQ Plus nationwide in the US, a wrist-worn neuromodulation device that delivers patterned electrical stimulation through the skin to peripheral nerves for temporary relief of hand tremor in essential tremor and Parkinson's disease. The system adds three selectable stimulation modes and a mandatory calibration step before each session that reads the user's current tremor and adjusts output accordingly. Company-cited data presented at the American Academy of Neurology reported that 76% to 89% of patients achieved at least a 1-point reduction on the clinician-rated TETRAS scale, though study size and mean effect were not disclosed.
Key Points
- Wrist device calibrates to tremor state before each stimulation session
- Three selectable waveform modes; patient-preferred mode improved daily-activity scores
- 76–89% achieved 1-point TETRAS reduction; sample size undisclosed
Longevity Analysis
Tremor fluctuates across the day with fatigue, stress load, caffeine, and sleep debt, which makes a fixed stimulation setting a poor match for a moving target — recalibration before each use treats the nervous system as a variable rather than a constant. The underlying principle extends well past movement disorders: therapies that read the body's state in real time and adjust output accordingly tend to outperform static protocols, whether the target is nerve signaling, circadian timing, or training load. Functional independence in eating, drinking, and writing is a concrete determinant of healthspan, and non-invasive peripheral stimulation occupying the territory between pharmacology and brain surgery expands the options available before more drastic interventions are considered.
Original published by Longevity.Technology, by Kyle Umipig.